Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9.
Lancet Neurol. 2021.
PMID: 34146511
Clinical Trial.
[Determination of needs of terminally ill patients in the hospice care].
Buzgová R, Havelková K.
Buzgová R, et al. Among authors: havelkova k.
Cas Lek Cesk. 2012;151(4):190-5.
Cas Lek Cesk. 2012.
PMID: 22679685
Czech.
Item in Clipboard
Cite
Cite